6-methyl-1,3,8-trichlorodibenzofuran has been researched along with alpha-naphthoflavone in 3 studies
Studies (6-methyl-1,3,8-trichlorodibenzofuran) | Trials (6-methyl-1,3,8-trichlorodibenzofuran) | Recent Studies (post-2010) (6-methyl-1,3,8-trichlorodibenzofuran) | Studies (alpha-naphthoflavone) | Trials (alpha-naphthoflavone) | Recent Studies (post-2010) (alpha-naphthoflavone) |
---|---|---|---|---|---|
25 | 0 | 3 | 665 | 1 | 142 |
Protein | Taxonomy | 6-methyl-1,3,8-trichlorodibenzofuran (IC50) | alpha-naphthoflavone (IC50) |
---|---|---|---|
Carboxylic ester hydrolase | Sus scrofa (pig) | 0.0478 | |
cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 2.3034 | |
Cytochrome P450 1A1 | Homo sapiens (human) | 0.1921 | |
Cytochrome P450 1A2 | Homo sapiens (human) | 0.1698 | |
Aromatase | Homo sapiens (human) | 1.035 | |
Substance-K receptor | Homo sapiens (human) | 5.8471 | |
Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.01 | |
Thromboxane-A synthase | Homo sapiens (human) | 6.7608 | |
Adenosine receptor A1 | Homo sapiens (human) | 1.1325 | |
Aryl hydrocarbon receptor | Mus musculus (house mouse) | 0.025 | |
Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.05 | |
DNA-dependent protein kinase catalytic subunit | Homo sapiens (human) | 4.98 | |
Cytochrome P450 1B1 | Homo sapiens (human) | 0.0449 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 1.355 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Ballarotto, M; Dolciami, D; Fallarino, F; Gargaro, M; López-Cara, LC; Macchiarulo, A | 1 |
Merchant, M; Safe, S | 1 |
Krishnan, V; Merchant, M; Safe, S | 1 |
1 review(s) available for 6-methyl-1,3,8-trichlorodibenzofuran and alpha-naphthoflavone
Article | Year |
---|---|
Targeting Aryl hydrocarbon receptor for next-generation immunotherapies: Selective modulators (SAhRMs) versus rapidly metabolized ligands (RMAhRLs).
Topics: Animals; Humans; Immune System Diseases; Immunotherapy; Ligands; Molecular Structure; Receptors, Aryl Hydrocarbon | 2020 |
2 other study(ies) available for 6-methyl-1,3,8-trichlorodibenzofuran and alpha-naphthoflavone
Article | Year |
---|---|
In vitro inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced activity by alpha-naphthoflavone and 6-methyl-1,3,8-trichlorodibenzofuran using an aryl hydrocarbon (Ah)-responsive construct.
Topics: Animals; Benzoflavones; Benzofurans; Chloramphenicol O-Acetyltransferase; Cytochrome P-450 Enzyme System; Enzyme Induction; Gene Expression; Mice; Polychlorinated Dibenzodioxins; Rats; Receptors, Aryl Hydrocarbon; Tumor Cells, Cultured | 1995 |
Mechanism of action of alpha-naphthoflavone as an Ah receptor antagonist in MCF-7 human breast cancer cells.
Topics: Benzoflavones; Benzofurans; Breast Neoplasms; Cell Division; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme System; Enzyme Induction; Gene Expression Regulation, Neoplastic; Humans; Oxidoreductases; Polychlorinated Dibenzodioxins; Receptors, Aryl Hydrocarbon; Receptors, Drug; Receptors, Estrogen; Tumor Cells, Cultured | 1993 |